These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7936495)
21. Obstructive parotitis secondary to an acute masseteric bend. Reddy R; White DR; Gillespie MB ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):12-5. PubMed ID: 22156562 [TBL] [Abstract][Full Text] [Related]
22. The treatment of masseter hypertrophy with botulinum toxin type A. Al-Ahmad HT; Al-Qudah MA Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107 [TBL] [Abstract][Full Text] [Related]
27. Simultaneous Bilateral Hypertrophies of the Parotid Gland and Masseter Muscle: Case Report. Prabhu R; Mandel L J Oral Maxillofac Surg; 2017 Jan; 75(1):149-152. PubMed ID: 27528104 [TBL] [Abstract][Full Text] [Related]
28. [Masseteric hypertrophy]. Chen YR Taiwan Yi Xue Hui Za Zhi; 1985 Jan; 84(1):96-101. PubMed ID: 3858434 [No Abstract] [Full Text] [Related]
29. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases. Baş B; Ozan B; Muğlali M; Celebi N Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin for treatment of masseteric hypertrophy. Hui AC J Neurol; 2002 Mar; 249(3):345. PubMed ID: 11993538 [No Abstract] [Full Text] [Related]
31. Application of magnetic resonance imaging and ultrasonography to preoperative evaluation of masseteric hypertrophy. Sano K; Ninomiya H; Sekine J; Pe MB; Inokuchi T J Craniomaxillofac Surg; 1991 Jul; 19(5):223-6. PubMed ID: 1894741 [TBL] [Abstract][Full Text] [Related]
33. Difficult intubation in a patient with benign masseteric muscle hypertrophy. Jimenez LF Br J Anaesth; 2001 Feb; 86(2):291-2. PubMed ID: 11573683 [No Abstract] [Full Text] [Related]
34. Benign masseteric hypertrophy; a syndrome of importance in the differential diagnosis of parotid tumors. BARTON RT J Am Med Assoc; 1957 Aug; 164(15):1646-7. PubMed ID: 13448915 [No Abstract] [Full Text] [Related]
35. The medical management of masseteric hypertrophy with botulinum toxin. Finn S; Ryan P; Sleeman D J Ir Dent Assoc; 2000; 46(3):84-6. PubMed ID: 11323940 [TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin type A treatment of cosmetically disturbing masseteric hypertrophy]. Rijsdijk BA; van ES RJ; Zonneveld FW; Steenks MH; Koole R Ned Tijdschr Geneeskd; 1998 Mar; 142(10):529-32. PubMed ID: 9623101 [TBL] [Abstract][Full Text] [Related]
37. Sonographic findings in masseter-muscle metastases. Ahuja AT; King AD; Bradley MJ; Yeo WW; Mok TS; Metreweli C J Clin Ultrasound; 2000; 28(6):299-302. PubMed ID: 10867669 [TBL] [Abstract][Full Text] [Related]
38. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate. Kwon JS; Kim ST; Jeon YM; Choi JH Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136 [TBL] [Abstract][Full Text] [Related]
39. [The genesis and symptoms of masseter muscle hypertrophy]. Röthler G Osterr Z Stomatol; 1983; 80(7-8):252-68 contd. PubMed ID: 6583645 [No Abstract] [Full Text] [Related]
40. [The genesis and symptoms of masseter muscle hypertrophy]. Röthler G Osterr Z Stomatol; 1983 Sep; 80(9):312-32 concl. PubMed ID: 6583648 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]